All In Biotech

Drug Trial Radar · NCT01911364

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

A 52-wk Randomized Double Blind Parallel Trial: Combination of Beclometasone+Formoterol+Glycopyrrolate vs Tiotropium and vs Combination of Beclometasone+Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

Last checked: Nov 19, 2026Latest source record: Oct 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 3,686 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,686

Actual

Start

Jan 2014

Primary completion

Mar 2016

Study completion Mar 2016

Sponsor

Lead sponsor
Chiesi Farmaceutici S.p.A.Industry
Sponsor type
Industry
First posted
Jul 30, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the triple combination of beclometasone dipropionate+Formoterol fumarate+Glycopyrrolate bromide is effective for the treatment of severe COPD patients (chronic obstructive pulmonary disease)

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • BDP/FF/GBDrug

    Superiority over Tiotropium

  • TiotropiumDrug

    Superiority of CHF5993 over Tiotropium

  • BDP/FF + TiotropiumDrug

    non inferiority vs CHF5993

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. COPD exacerbation rateTime frame: 52 weeks

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Institut für klinische Forschung

    Hessen, Germany

  • Csongrád Megyei Mellkasi Betegségek Szakkórháza

    Szeged, Hungary

  • Azienda Ospedaliera Perugia

    Perugia, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.